This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| CASIS | |
|---|---|
| Name | Center for the Advancement of Science in Space |
| Abbr | CASIS |
| Formation | 2011 |
| Purpose | Management of research on the International Space Station National Lab |
| Headquarters | United States |
| Region served | Worldwide |
| Leader title | Chief Executive Officer |
| Parent organization | Space Station Utilization |
CASIS
The Center for the Advancement of Science in Space (CASIS) is a non-profit organization designated to manage utilization of the United States National Laboratory aboard the International Space Station. It serves as a broker between academic institutions, commercial enterprises, and government agencies to enable research aboard the ISS and to translate microgravity results into applications relevant to NASA, industry, and public health. CASIS operates at the intersection of orbital platforms, biotechnology, materials science, and aerospace commercialization.
CASIS administers access to the United States National Laboratory on the International Space Station, coordinating payload development, flight integration, and operations with partners such as NASA, private companies like SpaceX and Northrop Grumman, and academic centers including Massachusetts Institute of Technology and Johns Hopkins University. The organization engages stakeholders from the National Institutes of Health, National Science Foundation, and multinational industrial corporations such as Boeing and Merck & Co. to advance microgravity research in fields like protein crystallography, fluid physics, and additive manufacturing. CASIS also liaises with technology incubators, venture capital firms, and standards bodies such as International Organization for Standardization to support commercialization pathways.
CASIS was created after policy decisions surrounding the extension of the International Space Station program and the designation of a US National Laboratory to promote civilian research in low Earth orbit. Its formation followed legislative and administrative actions tied to the National Aeronautics and Space Act era and programmatic shifts at NASA Headquarters. Early operational years involved coordination with flight providers from the Commercial Resupply Services era including missions by Orbital Sciences Corporation and later contractors. Over time, CASIS expanded relationships with universities like Stanford University and University of California, Berkeley and industry partners including 3M and Procter & Gamble.
CASIS’s mission emphasizes enabling research aboard the ISS National Lab to advance scientific knowledge and foster commercial opportunities. Programs administered by CASIS include solicitation mechanisms similar to research grants and cooperative agreements with institutions such as Brookhaven National Laboratory and Argonne National Laboratory, translational initiatives aimed at pharmaceutical development with companies like Pfizer and Johnson & Johnson, and educational outreach collaborating with organizations such as Smithsonian Institution and American Museum of Natural History. CASIS supports payloads in disciplines represented by research centers like Cold Spring Harbor Laboratory and Salk Institute for Biological Studies, and it promotes STEM engagement with partners such as FIRST and Boy Scouts of America.
Governance of CASIS involves a board of directors drawn from sectors represented by firms like Raytheon Technologies and universities such as Yale University, with oversight interfaces to NASA program offices and policy stakeholders in Congress. Funding sources for CASIS historically have included federal appropriations routed through NASA, private sponsorships from corporations including Google and Intel Corporation, and in-kind support from aerospace providers such as Sierra Nevada Corporation. Financial arrangements have encompassed cooperative agreements, reimbursable contracts with entities like United Launch Alliance, and research partnerships with national laboratories under the purview of the Department of Energy.
CASIS has forged collaborations across a broad landscape: aerospace firms (SpaceX, Blue Origin), pharmaceutical companies (Amgen, Novartis), academic institutions (University of Pennsylvania, Columbia University), and non-profit organizations (Bill & Melinda Gates Foundation, The Rockefeller Foundation). It has coordinated flight opportunities with launch integrators such as Arianespace and with international space agencies including the Canadian Space Agency, European Space Agency, and Japan Aerospace Exploration Agency. Educational and outreach collaborations have involved organizations like NASA Jet Propulsion Laboratory, American Chemical Society, and museum networks including The Field Museum.
Among projects facilitated through CASIS-managed access to the ISS National Lab are protein crystallization studies linked to firms like Merck and institutions such as University of Texas Southwestern Medical Center, fluid dynamics experiments with researchers from California Institute of Technology, and materials science demonstrations with partners including GE Aviation. Biomedical research has included cell culture and organoid studies by groups at Harvard Medical School and Mayo Clinic, while technology demonstrations have featured microgravity 3D printing efforts by teams associated with Made In Space and advanced optics tests in collaboration with Lockheed Martin. Educational initiatives have included student experiments from Massachusetts Institute of Technology and outreach programs with National Science Teachers Association.
CASIS has faced scrutiny regarding allocation of resources, transparency of funding relationships with corporate partners such as Pfizer and Procter & Gamble, and oversight by agencies like Government Accountability Office. Debates have involved comparisons to international utilization models used by the European Space Agency and Roscosmos, questions raised by policy analysts in think tanks such as Brookings Institution and Center for Strategic and International Studies, and critiques from academic commentators at institutions like University of Michigan over prioritization of commercial versus basic research. Audits and investigative reporting have examined contractual terms with private entities and the balance of public benefit against corporate sponsorship.
Category:Space organizations